The US federal government is now left with 63 million doses of the antimalarial drug hydroxychloroquine sulfate (HCQ) in its Strategic National Stockpile after the US Food and Drug Administration (FDA) on Monday revoked permission for the drug to be used for COVID-19 treatment.